Fingerprint
Dive into the research topics of 'Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy'. Together they form a unique fingerprint.- Sort by:
- Weight
- Alphabetically
Toosendanin, a late-stage autophagy inhibitor, sensitizes triple-negative breast cancer to irinotecan chemotherapy
Shuang Zhang, Yu Dong, Xiuping Chen, Chris Soon Heng Tan, Min Li, Kai Miao, Jia Hong Lu*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
3
Citations
(Scopus)